Invitrogen™ SPRYD7 Monoclonal Antibody (2G4)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA522347

Catalog No. PIMA522347

Description

Peptide Sequence: MHSLVMRNDG ALYHNNEEKN RLPANSLPQE GDVVGITYDH VELNVYLNGK NMHCPASGIR GTVYPVVYVD DSAILDCQFS EFYHTPPPGF EKILFEQQIF.

C13orf1, also named as SPRYD7 and CLLD6, is involved in hematopoiesis via NOTCH signaling. C13orf1 plays an important role in the pathogenesis of B-CLL. There are isoforms of C13orf1 with MW 15-17 kDa and 19-22 kDa.

Specifications

• Antigen: SPRYD7
• Classification: Monoclonal
• Concentration: 1.0 mg/mL
• Formulation: PBS with no preservative; pH 7.4
• Gene Accession No.: Q5M7T2, Q5W111
• Gene Symbols: Spryd7
• Immunogen: C13orf1 (NP_065189, 97 a.a. ~ 196 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
• Quantity: 100 μg
• Primary or Secondary: Primary
• Target Species: Human, Rat
• Product Type: Antibody
• Isotype: IgG1 κ

• Applications: ELISA, Western Blot
• Clone: 2G4
• Conjugate: Unconjugated
• Gene: Spryd7
• Gene Alias: 6330409N04Rik; C13orf1; Chronic lymphocytic leukemia deletion region gene 6 protein; chronic lymphocytic leukemia deletion region gene 6 protein homolog; CLL deletion region gene 6 protein; CLL deletion region gene 6 protein homolog; Clld6; PUR1; RGD1306437; SPRY domain containing 7; SPRY domain-containing protein 7; SPRYD7
• Host Species: Mouse
• Purification Method: Affinity chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 290303, 57213
• Content And Storage: -20°C, Avoid Freeze/Thaw Cycles
• Form: Liquid